New Key Statistics Module, Z-Score and F-Score
NAS:IPSC Key Ratios
| Market Cap $ M | 130.46 |
| Enterprise Value $ M | -7.87 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.59 |
| Price/Sales | 53.79 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 2.00 |
| EPS (TTM) $ | -2.03 |
| Beneish M-Score | -4.48 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.06 |
| EV-to-EBITDA | 0.07 |
| PEG | -- |
| Shares Outstanding M | 84.72 |
| Net Margin (%) | -6,434.23 |
| Operating Margin % | -6,283.40 |
| Pre-tax Margin (%) | -6,446.67 |
| Quick Ratio | 10.62 |
| Current Ratio | 10.62 |
| ROA % (ttm) | -33.86 |
| ROE % (ttm) | -62.47 |
| ROIC % (ttm) | -60.23 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.50 |
IPSC Number of Guru Trades
IPSC Volume of Guru Trades
Gurus Latest Trades with NAS:IPSC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:IPSC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Century Therapeutics Inc Insider Transactions
No Available Data
News about NAS:IPSC
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers